Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New Product Briefs

This article was originally published in The Gray Sheet

Executive Summary

Product announcements from LivaNova, Smith & Nephew, Medtronic, Boston Scientific and Animas.

You may also be interested in...



FDA Approves Edwards' Rapid-Deployment Minimally Invasive Surgical Valve

The system combines the company's proven tissue surgical valve platform with technology developed for transcatheter valves.

Diabetes Devices Move Ahead: Updates From JP Morgan

Insulin pump-maker Insulet, continuous glucose monitoring firm DexCom, and Medtronic provided updates on their diabetes device efforts at this year's JP Morgan Healthcare Conference in San Francisco.

Let The U.S. Drug-Coated Balloon Battle Begin

Medtronic gained FDA approval for its drug-coated balloon for the peripheral artery, as expected, and it is now gunning to take share from first-to-market C.R. Bard with the help of impressive clinical data and a formidable Covidien peripheral vascular device sales force.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT034888

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel